BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 16420784)

  • 21. Malignant progression and blockade of angiogenesis in a murine transgenic model of neuroblastoma.
    Chesler L; Goldenberg DD; Seales IT; Satchi-Fainaro R; Grimmer M; Collins R; Struett C; Nguyen KN; Kim G; Tihan T; Bao Y; Brekken RA; Bergers G; Folkman J; Weiss WA
    Cancer Res; 2007 Oct; 67(19):9435-42. PubMed ID: 17909053
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antiangiogenic and antitumor effects of tranilast on mouse lung carcinoma cells.
    Yatsunami J; Aoki S; Fukuno Y; Kikuchi Y; Kawashima M; Hayashi SI
    Int J Oncol; 2000 Dec; 17(6):1151-6. PubMed ID: 11078800
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The antiangiogenic agents TNP-470 and 2-methoxyestradiol inhibit the growth of angiosarcoma in mice.
    Arbiser JL; Panigrathy D; Klauber N; Rupnick M; Flynn E; Udagawa T; D'Amato RJ
    J Am Acad Dermatol; 1999 Jun; 40(6 Pt 1):925-9. PubMed ID: 10365923
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Contribution of angiogenesis to the progression of colon cancer: possible inhibitory effect of angiogenesis inhibitor TNP-470 on tumor growth and hepatic metastasis.
    Takatsuka S; Yamada N; Sawada T; Ogawa Y; Maeda K; Ohira M; Ishikawa T; Nishino H; Seki S; Hirakawa-YS Chung K
    Int J Oncol; 2000 Aug; 17(2):253-8. PubMed ID: 10891532
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Growth inhibition of liver metastases by the anti-angiogenic drug TNP-470.
    Gervaz P; Scholl B; Padrun V; Gillet M
    Liver; 2000 Apr; 20(2):108-13. PubMed ID: 10847478
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of TNP-470-induced modifications to cell functions in HUVEC and cancer cells.
    Farinelle S; Malonne H; Chaboteaux C; Decaestecker C; Dedecker R; Gras T; Darro F; Fontaine J; Atassi G; Kiss R
    J Pharmacol Toxicol Methods; 2000; 43(1):15-24. PubMed ID: 11091126
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Angiogenesis and angiogenesis inhibitors in cancer.
    Giavazzi R; Taraboletti G
    Forum (Genova); 1999; 9(3):261-72. PubMed ID: 10504172
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Angiogenesis research enjoys growth spurt in the 1990s.
    Ziegler J
    J Natl Cancer Inst; 1996 Jun; 88(12):786-8. PubMed ID: 8637041
    [No Abstract]   [Full Text] [Related]  

  • 29. Effect of angiogenesis inhibitor TNP-470 on the growth, blood flow, and microvessel density in xenografts of human uterine carcinosarcoma in nude mice.
    Emoto M; Ishiguro M; Iwasaki H; Kikuchi M; Kawarabayashi T
    Gynecol Oncol; 2003 Apr; 89(1):88-94. PubMed ID: 12694659
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vascular endothelial cell growth factor (VEGF), an emerging target for cancer chemotherapy.
    Shinkaruk S; Bayle M; Laïn G; Déléris G
    Curr Med Chem Anticancer Agents; 2003 Mar; 3(2):95-117. PubMed ID: 12678905
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel bicyclic oxazolone derivatives as anti-angiogenic agents.
    Perron-Sierra FM; Pierré A; Burbridge M; Guilbaud N
    Bioorg Med Chem Lett; 2002 Jun; 12(11):1463-6. PubMed ID: 12031320
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-angiogenesis: towards a molecular tourniquet.
    Geisow MJ
    Trends Biotechnol; 1991 Mar; 9(3):78-9. PubMed ID: 1370030
    [No Abstract]   [Full Text] [Related]  

  • 33. Angiogenesis in bladder cancer--prognostic marker and target for future therapy.
    Streeter EH; Harris AL
    Surg Oncol; 2002 Jun; 11(1-2):85-100. PubMed ID: 12031871
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of TNP-470, a potent angiogenesis inhibitor, on growth of hematopoietic progenitors.
    Hasuike T; Hino M; Yamane T; Nishizawa Y; Morii H; Tatsumi N
    Eur J Haematol; 1997 Apr; 58(4):293-4. PubMed ID: 9186544
    [No Abstract]   [Full Text] [Related]  

  • 35. Quantitative estimates of vascularity in solid tumors by non-invasive near-infrared spectroscopy.
    Kragh M; Quistorff B; Lund EL; Kristjansen PE
    Neoplasia; 2001; 3(4):324-30. PubMed ID: 11571632
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antitumor effect of TNP-470 is not associated to decrease of angiogenesis in an experimental malignant neuroectodermic tumor.
    Morales C; Zurita M; Vaquero J
    J Neurooncol; 2002 Jun; 58(2):131-6. PubMed ID: 12164684
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Angiogenesis in human gliomas: prognostic and therapeutic implications.
    Johnson JP; Bruce JN
    EXS; 1997; 79():29-46. PubMed ID: 9002219
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of angiogenesis inhibitor TNP-470 on vascular formation in pituitary tumors induced by estrogen in rats.
    Takechi A
    Neurol Med Chir (Tokyo); 1994 Nov; 34(11):729-33. PubMed ID: 7533265
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acceleration of follicular development by administration of vascular endothelial growth factor in cycling female rats.
    Iijima K; Jiang JY; Shimizu T; Sasada H; Sato E
    J Reprod Dev; 2005 Feb; 51(1):161-8. PubMed ID: 15750308
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of angiogenesis inhibitor TNP-470 on tamoxifen-stimulated MCF-7 breast tumors in nude mice.
    Takei H; Lee ES; Cisneros A; Jordan VC
    Cancer Lett; 2000 Jul; 155(2):129-35. PubMed ID: 10822127
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.